Dehydroepiandrosterone sulfate levels associated with decreased malaria parasite density and increased hemoglobin concentration in pubertal girls from western Kenya

Journal of Infectious Diseases

Volumn 188, Issue 2, 2003, Pages 297-304

  Leenstra, Tjalling ^a,b   Ter Kuile, Feiko O ^a,b,e   Kariuki, Simon K ^a   Nixon, Christian P ^c   Oloo, Aggrey J ^a   Kager, Piet A ^b   Kurtis, Jonathan D ^c,d,f  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c International Health Institute   (United States)

^d BROWN UNIVERSITY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; PRASTERONE SULFATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; KENYA; MAJOR CLINICAL STUDY; MALARIA; PARASITE IDENTIFICATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTOZOAL INFECTION; PUBERTY;

ADOLESCENT; ANIMALS; CHILD; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; IMMUNITY, NATURAL; KENYA; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PUBERTY; REGRESSION ANALYSIS;

EID: 0042816540     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/376508     Document Type: Article

References (46)

1. Snow RW, Craig M, Deichmann U, Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ 1999; 77:624-40.
2. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002; 415:680-5.
3. Bloland PB, Boriga DA, Ruebush TK, et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission. II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg 1999; 60:641-8.
4. Rogier C, Ly AB, Tall A, Cisse B, Trape JF. Plasmodium falciparum clinical malaria in Dielmo, a holoendemic area in Senegal: no influence of acquired immunity on initial symptomatology and severity of malaria attacks. Am J Trop Med Hyg 1999; 60:410-20.
5. Trape JF, Zoulani A, Quinet MC. Assessment of the incidence and prevalence of clinical malaria in semi-immune children exposed to intense and perennial transmission. Am J Epidemiol 1987; 126:193-201.
6. Snow RW, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997; 349:1650-4.
7. Brooker S, Guyatt H, Omumbo J, Shretta R, Drake L, Ouma J. Situation analysis of malaria in school-aged children in Kenya: what can be done? Parasitol Today 2000; 16:183-6.
8. Baird JK, Jones TR, Danudirgo EW, et al. Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am J Trop Med Hyg 1991; 45:65-76.
9. Baird JK, Purnomo, Basri H, et al. Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. Am J Trop Med Hyg 1993; 49:707-19.
10. Kurtis JD, Mtalib R, Onyango FK, Duffy PE. Human resistance to Plasmodium falciparum increases during puberty and is predicted by dehydroepiandrosterone sulfate levels. Infect Immun 2001; 69:123-8.
11. Phillips-Howard PA, Nahlen BL, Alaii JA, et al. The efficacy of permethrin-treated bed nets on child mortality and morbidity in western Kenya. I. Development of infrastructure and description of study site. Am J Trop Med Hyg 2003; 68:3-9.
12. Bloland PB, Ruebush TK, McCormick JB, et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission. I. Description of study site, general methodology, and study population. Am J Trop Med Hyg 1999; 60:635-40.
13. McElroy PD, Lal AA, Hawley WA, et al. Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asembo Bay Cohort Project. Am J Trop Med Hyg 1999; 61:932-40.
14. Phillips-Howard PA, ter Kuile FO, Nahlen BL, et al. The efficacy of permethrin-treated bed nets on child mortality and morbidity in western Kenya. II. Study design and methods. Am J Trop Med Hyg 2003; 68:10-5.
15. Kirkwood B. Essentials of medical statistics. Oxford, UK: Blackwell Scientific Publications, 1998.
16. Bennett S, Woods T, Linyanage WM, Smith DL. A simplified general model for cluster-sample surveys of health in developing countries. World Health Stat Q 1991; 44:98-106.
17. Tanner J. Growth at adolescence. 2nd ed. Oxford, UK: Blackwell Scientific Publications, 1962.
18. World Health Organization Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ 1986; 64:929-41.
19. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; 314:1-27.
20. Knight WB, Hiatt RA, Cline BL, Ritchie LS. A modification of the formol-ether concentration technique for increased sensitivity in detecting Schistosoma mansoni eggs. Am J Trop Med Hyg 1976; 25:818-23.
21. Edson DC, Smith JW. Comparison of concentration procedures for detection of Schistosoma mansoni eggs in a CAP Parasitology Survey specimen. Am J Clin Pathol 1982; 78:671-2.
22. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosoma mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400.
23. Shaker ZA, Hassan SI, el-Attar GM, et al. Use of Kato and nucleopore techniques for qualitative diagnosis of schistosomiasis. J Egypt Soc Parasitol 1994; 24:656-62.
24. Tietz NW. Clinical guide to laboratory tests. 3rd ed. Philadelphia: WB Saunders, 1995.
25. Konijn AM. Iron metabolism in inflammation. Baillieres Clin Haematol 1994; 7:829-49.
26. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 1990; 75:1870-6.
27. Baird JK. Host age as determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 1995; 11:105-11.
28. Baird JK, Masbar S, Basri H, Tirtokusumo S, Subianto B, Hoffman SL. Age-dependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. J Infect Dis 1998; 178:592-5.
29. Yang BC, Liu CW, Chen YC, Yu CK. Exogenous dehydroepiandrosterone modified the expression of T helper-related cytokines in NZB/NZW F1 mice. Immunol Invest 1998; 27:291-302.
30. Araghi-Niknam M, Zhang Z, Jiang S, Call O, Eskelson CD, Watson RR. Cytokine dysregulation and increased oxidation is prevented by dehydroepiandrosterone in mice infected with murine leukemia retrovirus. Proc Soc Exp Biol Med 1997; 216:386-91.
31. Araghi-Niknam M, Liang B, Zhang Z, Ardestani SK, Watson RR. Modulation of immune dysfunction during murine leukaemia retrovirus infection of old mice by dehydroepiandrosterone sulphate (DHEAS). Immunology 1997; 90:344-9.
32. Di Santo E, Foddi MC, Ricciardi-Castagnoli P, Mennini T, Ghezzi P. DHEAS inhibits TNF production in monocytes, astrocytes and microglial cells. Neuroimmunomodulation 1996; 3:285-8.
33. Di Santo E, Sironi M, Mennini T, et al. A glucocorticoid receptor-independent mechanism for neurosteroid inhibition of tumor necrosis factor production. Eur J Pharmacol 1996; 299:179-86.
34. Danenberg HD, Alpert G, Lustig S, Ben-Nathan D. Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production. Antimicrob Agents Chemother 1992; 36:2275-9.
35. Araneo BA, Woods ML 2nd, Daynes RA. Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis 1993; 167:830-40.
36. Araneo B, Dowell T, Woods ML, Daynes R, Judd M, Evans T. DHEAS as an effective vaccine adjuvant in elderly humans: proof-of-principle studies. Ann N Y Acad Sci 1995; 774:232-48.
37. Degelau J, Guay D, Hallgren H. The effect of DHEAS on influenza vaccination in aging adults. J Am Geriatr Soc 1997; 45:747-51.
38. Voors AW, Frank GC, Srinivasan SR, Webber LS, Berenson GS. Hemoglobin levels and dietary iron in pubescent children in a biracial community. Public Health Rep 1981; 96:45-9.
39. Arquitt AB, Stoecker BJ, Hermann JS, Winterfeldt EA. Dehydroepiandrosterone sulfate, cholesterol, hemoglobin, and anthropometric measures related to growth in male adolescents. J Am Diet Assoc 1991; 91:575-9.
40. Kurtzhals JA, Addae MM, Akanmori BD, et al. Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren. Trans R Soc Trop Med Hyg 1999; 93:623-7.
41. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis 1997; 25:888-95.
42. Baynes RD. Assessment of iron status. Clin Biochem 1996; 29:209-15.
43. Inserra P, Zhang Z, Ardestani SK, et al. Modulation of cytokine production by dehydroepiandrosterone (DHEA) plus melatonin (MLT) supplementation of old mice. Proc Soc Exp Biol Med 1998; 218:76-82.
44. Spencer NF, Norton SD, Harrison LL, Li GZ, Daynes RA. Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp Gerontol 1996; 31:393-408.
45. James K, Premchand N, Skibinska A, Skibinski G, Nicol M, Mason JI. IL-6, DHEA and the ageing process. Mech Ageing Dev 1997; 93:15-24.
46. Ben-Nathan D, Padgett DA, Loria RM. Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity. J Med Microbiol 1999; 48:425-31.